Lincoln Pharmaceuticals Limited

NSEI:LINCOLN Stock Report

Market Cap: ₹12.0b

Lincoln Pharmaceuticals Management

Management criteria checks 4/4

Lincoln Pharmaceuticals' CEO is Mahendrabhai Patel, appointed in Jun 2018, has a tenure of 5.83 years. total yearly compensation is ₹3.32M, comprised of 99.1% salary and 0.9% bonuses, including company stock and options. directly owns 7.93% of the company’s shares, worth ₹949.27M. The average tenure of the management team and the board of directors is 8.7 years and 28.7 years respectively.

Key information

Mahendrabhai Patel

Chief executive officer

₹3.3m

Total compensation

CEO salary percentage99.1%
CEO tenure5.8yrs
CEO ownership7.9%
Management average tenure8.7yrs
Board average tenure28.7yrs

Recent management updates

Recent updates

Lincoln Pharmaceuticals Limited's (NSE:LINCOLN) Business And Shares Still Trailing The Market

Mar 14
Lincoln Pharmaceuticals Limited's (NSE:LINCOLN) Business And Shares Still Trailing The Market

Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?

Nov 04
Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?

Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50

Sep 14
Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50

Lincoln Pharmaceuticals (NSE:LINCOLN) Is Paying Out A Dividend Of ₹1.50

Aug 31
Lincoln Pharmaceuticals (NSE:LINCOLN) Is Paying Out A Dividend Of ₹1.50

Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50

Sep 12
Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50

Lincoln Pharmaceuticals (NSE:LINCOLN) Is Due To Pay A Dividend Of ₹1.50

Aug 29
Lincoln Pharmaceuticals (NSE:LINCOLN) Is Due To Pay A Dividend Of ₹1.50

If You Like EPS Growth Then Check Out Lincoln Pharmaceuticals (NSE:LINCOLN) Before It's Too Late

Feb 14
If You Like EPS Growth Then Check Out Lincoln Pharmaceuticals (NSE:LINCOLN) Before It's Too Late

Should You Be Adding Lincoln Pharmaceuticals (NSE:LINCOLN) To Your Watchlist Today?

Aug 16
Should You Be Adding Lincoln Pharmaceuticals (NSE:LINCOLN) To Your Watchlist Today?

Here's Why I Think Lincoln Pharmaceuticals (NSE:LINCOLN) Is An Interesting Stock

May 06
Here's Why I Think Lincoln Pharmaceuticals (NSE:LINCOLN) Is An Interesting Stock

Is Lincoln Pharmaceuticals Limited (NSE:LINCOLN) A Smart Choice For Dividend Investors?

Apr 03
Is Lincoln Pharmaceuticals Limited (NSE:LINCOLN) A Smart Choice For Dividend Investors?

Does Lincoln Pharmaceuticals (NSE:LINCOLN) Have A Healthy Balance Sheet?

Mar 15
Does Lincoln Pharmaceuticals (NSE:LINCOLN) Have A Healthy Balance Sheet?

Could The Market Be Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Given Its Attractive Financial Prospects?

Feb 28
Could The Market Be Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Given Its Attractive Financial Prospects?

Insider Buying: The Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Whole Time Director Just Bought 15% More Shares

Feb 12
Insider Buying: The Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Whole Time Director Just Bought 15% More Shares

Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?

Feb 01
Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?

Lincoln Pharmaceuticals (NSE:LINCOLN) Shareholders Booked A 27% Gain In The Last Five Years

Jan 19
Lincoln Pharmaceuticals (NSE:LINCOLN) Shareholders Booked A 27% Gain In The Last Five Years

Trade Alert: The Whole Time Director Of Lincoln Pharmaceuticals Limited (NSE:LINCOLN), Munjal Patel, Has Just Spent ₹20m Buying 9.2% More Shares

Jan 06
Trade Alert: The Whole Time Director Of Lincoln Pharmaceuticals Limited (NSE:LINCOLN), Munjal Patel, Has Just Spent ₹20m Buying 9.2% More Shares

Why Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Is A Dividend Rockstar

Dec 27
Why Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Is A Dividend Rockstar

Lincoln Pharmaceuticals's (NSE:LINCOLN) Earnings Are Growing But Is There More To The Story?

Dec 14
Lincoln Pharmaceuticals's (NSE:LINCOLN) Earnings Are Growing But Is There More To The Story?

Have Insiders Been Buying Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Shares This Year?

Dec 01
Have Insiders Been Buying Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Shares This Year?

Declining Stock and Solid Fundamentals: Is The Market Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN)?

Nov 18
Declining Stock and Solid Fundamentals: Is The Market Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN)?

Is Lincoln Pharmaceuticals (NSE:LINCOLN) A Risky Investment?

Nov 05
Is Lincoln Pharmaceuticals (NSE:LINCOLN) A Risky Investment?

Is Now The Time To Put Lincoln Pharmaceuticals (NSE:LINCOLN) On Your Watchlist?

Oct 23
Is Now The Time To Put Lincoln Pharmaceuticals (NSE:LINCOLN) On Your Watchlist?

Lincoln Pharmaceuticals (NSE:LINCOLN) Shareholders Booked A 74% Gain In The Last Year

Oct 05
Lincoln Pharmaceuticals (NSE:LINCOLN) Shareholders Booked A 74% Gain In The Last Year

Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Vies For A Place In Your Dividend Portfolio: Here's Why

Sep 18
Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Vies For A Place In Your Dividend Portfolio: Here's Why

Trade Alert: The MD & Whole Time Director Of Lincoln Pharmaceuticals Limited (NSE:LINCOLN), Mahendrabhai Patel, Has Just Spent ₹2.4m Buying 2.0% More Shares

Aug 31
Trade Alert: The MD & Whole Time Director Of Lincoln Pharmaceuticals Limited (NSE:LINCOLN), Mahendrabhai Patel, Has Just Spent ₹2.4m Buying 2.0% More Shares

Earnings Working Against Lincoln Pharmaceuticals Limited's (NSE:LINCOLN) Share Price

Aug 21
Earnings Working Against Lincoln Pharmaceuticals Limited's (NSE:LINCOLN) Share Price

CEO Compensation Analysis

How has Mahendrabhai Patel's remuneration changed compared to Lincoln Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

₹873m

Sep 30 2023n/an/a

₹808m

Jun 30 2023n/an/a

₹769m

Mar 31 2023₹3m₹3m

₹729m

Dec 31 2022n/an/a

₹714m

Sep 30 2022n/an/a

₹674m

Jun 30 2022n/an/a

₹667m

Mar 31 2022₹3m₹3m

₹694m

Dec 31 2021n/an/a

₹709m

Sep 30 2021n/an/a

₹668m

Jun 30 2021n/an/a

₹647m

Mar 31 2021₹3m₹3m

₹623m

Dec 31 2020n/an/a

₹586m

Sep 30 2020n/an/a

₹560m

Jun 30 2020n/an/a

₹540m

Mar 31 2020₹2m₹2m

₹514m

Dec 31 2019n/an/a

₹510m

Sep 30 2019n/an/a

₹492m

Jun 30 2019n/an/a

₹453m

Mar 31 2019₹2m₹2m

₹487m

Dec 31 2018n/an/a

₹470m

Sep 30 2018n/an/a

₹495m

Jun 30 2018n/an/a

₹458m

Mar 31 2018₹2m₹2m

₹346m

Compensation vs Market: Mahendrabhai's total compensation ($USD39.83K) is about average for companies of similar size in the Indian market ($USD39.23K).

Compensation vs Earnings: Mahendrabhai's compensation has been consistent with company performance over the past year.

CEO

Mahendrabhai Patel (69 yo)

5.8yrs

Tenure

₹3,322,000

Compensation

Mr. Mahendrabhai Gulabdas Patel, B.A, LLB serves as Managing Director of Lincoln Pharmaceuticals Ltd. Mr. Patel has varied experience of chemicals, steel, finance etc. Mr. Patel handles corporate planning...

Leadership Team

NamePositionTenureCompensationOwnership
Mahendrabhai Patel
MD & Whole Time Director5.8yrs₹3.32m7.93%
₹ 949.3m
Darshit Shah
Chief Financial Officer5.1yrs₹1.18mno data
Trusha Shah
Company Secretary & Compliance Officer1.4yrs₹228.00kno data
Ashish Patel
Head of Sales & Marketing and Whole Time Director11.5yrs₹53.35k10.6%
₹ 1.3b
Hashmukhbhai Patel
Whole Time Director29.3yrs₹3.33m1.87%
₹ 223.3m
Munjal Patel
Whole Time Directorno data₹3.44m13.13%
₹ 1.6b
Sanjay Bhatt
Senior Manager of Operationno datano datano data
C. Kapadia
Head of Sales & Adminno datano datano data
Amit Dwivedi
Group Marketing Managerno datano datano data
Sachin Kapoor
Head of H R Dno datano datano data
K. Sompura
Head of Financeno datano datano data
Dhaval Gandhi
Head of Information Technology20.3yrsno datano data

8.7yrs

Average Tenure

48yo

Average Age

Experienced Management: LINCOLN's management team is seasoned and experienced (8.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Mahendrabhai Patel
MD & Whole Time Director29.3yrs₹3.32m7.93%
₹ 949.3m
Ashish Patel
Head of Sales & Marketing and Whole Time Director9.4yrs₹53.35k10.6%
₹ 1.3b
Hashmukhbhai Patel
Whole Time Director29.3yrs₹3.33m1.87%
₹ 223.3m
Munjal Patel
Whole Time Director9.4yrs₹3.44m13.13%
₹ 1.6b
Rajnikant Patel
Non-Executive Director29.3yrsno data3.78%
₹ 452.3m
Kishorbhai Shah
Non-Executive Chairman28.7yrsno data2.39%
₹ 285.9m
Saurin Jagdish Parikh
Independent Non-Executive Director6.1yrsno datano data

28.7yrs

Average Tenure

65yo

Average Age

Experienced Board: LINCOLN's board of directors are seasoned and experienced ( 28.7 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.